Skip to main content
Top
Published in: European Radiology 3/2023

20-10-2022 | Computed Tomography | Imaging Informatics and Artificial Intelligence

Two nomograms based on radiomics models using triphasic CT for differentiation of adrenal lipid-poor benign lesions and metastases in a cancer population: an exploratory study

Authors: Gongzheng Wang, Bing Kang, Jingjing Cui, Yan Deng, Yun Zhao, Congshan Ji, Ximing Wang

Published in: European Radiology | Issue 3/2023

Login to get access

Abstract

Objectives

To investigate the effectiveness of CT-based radiomics nomograms in differentiating adrenal lipid-poor benign lesions and metastases in a cancer population.

Methods

This retrospective study enrolled 178 patients with cancer history from three medical centres categorised as those with adrenal lipid-poor benign lesions or metastases. Patients were divided into training, validation, and external testing cohorts. Radiomics features were extracted from triphasic CT images (unenhanced, arterial, and venous) to establish three single-phase models and one triphasic radiomics model using logistic regression. Unenhanced and triphasic nomograms were established by incorporating significant clinico-radiological factors and radscores. The models were evaluated by the receiver operating characteristic curve, Delong’s test, calibration curve, and decision curve.

Results

Lesion side, diameter, and enhancement ratio resulted as independent factors and were selected into nomograms. The areas under the curves (AUCs) of unenhanced and triphasic radiomics models in validation (0.878, 0.914, p = 0.381) and external testing cohorts (0.900, 0.893, p = 0.882) were similar and higher than arterial and venous models (validation: 0.842, 0.765; testing: 0.814, 0.806). Unenhanced and triphasic nomograms yielded similar AUCs in validation (0.903, 0.906, p = 0.955) and testing cohorts (0.928, 0.946, p = 0.528). The calibration curves showed good agreement and decision curves indicated satisfactory clinical benefits.

Conclusion

Unenhanced and triphasic CT-based radiomics nomograms resulted as a useful tool to differentiate adrenal lipid-poor benign lesions from metastases in a cancer population. They exhibited similar predictive efficacies, indicating that enhanced examinations could be avoided in special populations.

Key Points

• All four radiomics models and two nomograms using triphasic CT images exhibited favourable performances in three cohorts to characterise the cancer population’s adrenal benign lesions and metastases.
• Unenhanced and triphasic radiomics models had similar predictive performances, outperforming arterial and venous models.
• Unenhanced and triphasic nomograms also exhibited similar efficacies and good clinical benefits, indicating that contrast-enhanced examinations could be avoided when identifying adrenal benign lesions and metastases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 56:95–101CrossRefPubMed Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 56:95–101CrossRefPubMed
2.
go back to reference Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1–G34CrossRefPubMed Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1–G34CrossRefPubMed
3.
go back to reference Spartalis E, Drikos I, Ioannidis A et al (2019) Metastatic carcinomas of the adrenal glands: from diagnosis to treatment. Anticancer Res 39:2699–2710CrossRefPubMed Spartalis E, Drikos I, Ioannidis A et al (2019) Metastatic carcinomas of the adrenal glands: from diagnosis to treatment. Anticancer Res 39:2699–2710CrossRefPubMed
5.
go back to reference Remer EM, Obuchowski N, Ellis JD, Rice TW, Adelstein DJ, Baker ME (2000) Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis. AJR Am J Roentgenol 174:1033–1039CrossRefPubMed Remer EM, Obuchowski N, Ellis JD, Rice TW, Adelstein DJ, Baker ME (2000) Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis. AJR Am J Roentgenol 174:1033–1039CrossRefPubMed
6.
go back to reference Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT (2018) Practical approach to adrenal imaging. Urol Clin North Am 45:365–387CrossRefPubMed Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT (2018) Practical approach to adrenal imaging. Urol Clin North Am 45:365–387CrossRefPubMed
7.
go back to reference Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415CrossRefPubMed Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415CrossRefPubMed
8.
go back to reference Mayo-Smith WW, Song JH, Boland GL et al (2017) Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:1038–1044CrossRefPubMed Mayo-Smith WW, Song JH, Boland GL et al (2017) Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:1038–1044CrossRefPubMed
9.
go back to reference Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics 21:995–1012CrossRefPubMed Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics 21:995–1012CrossRefPubMed
10.
go back to reference Koo HJ, Choi HJ, Kim HJ, Kim SO, Cho KS (2014) The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging. Eur Radiol 24:1410–1420CrossRefPubMed Koo HJ, Choi HJ, Kim HJ, Kim SO, Cho KS (2014) The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging. Eur Radiol 24:1410–1420CrossRefPubMed
11.
go back to reference Platzek I, Sieron D, Plodeck V, Borkowetz A, Laniado M, Hoffmann RT (2019) Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol 29:806–817CrossRefPubMed Platzek I, Sieron D, Plodeck V, Borkowetz A, Laniado M, Hoffmann RT (2019) Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol 29:806–817CrossRefPubMed
13.
go back to reference Porte HL, Ernst OJ, Delebecq T, Métois D, Lemaitre LG, Wurtz AJ (1999) Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer? Eur J Cardiothorac Surg 15:597–601CrossRefPubMed Porte HL, Ernst OJ, Delebecq T, Métois D, Lemaitre LG, Wurtz AJ (1999) Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer? Eur J Cardiothorac Surg 15:597–601CrossRefPubMed
14.
go back to reference Pagani JJ (1984) Non-small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosis. Cancer 53:1058–1060CrossRefPubMed Pagani JJ (1984) Non-small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosis. Cancer 53:1058–1060CrossRefPubMed
15.
go back to reference Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRefPubMed Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRefPubMed
16.
go back to reference Limkin EJ, Sun R, Dercle L et al (2017) Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol 28:1191–1206CrossRefPubMed Limkin EJ, Sun R, Dercle L et al (2017) Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol 28:1191–1206CrossRefPubMed
17.
go back to reference Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed
18.
go back to reference Kang B, Sun C, Gu H et al (2020) T1 stage clear cell renal cell carcinoma: A CT-based radiomics nomogram to estimate the risk of recurrence and metastasis. Front Oncol 10:579619CrossRefPubMedPubMedCentral Kang B, Sun C, Gu H et al (2020) T1 stage clear cell renal cell carcinoma: A CT-based radiomics nomogram to estimate the risk of recurrence and metastasis. Front Oncol 10:579619CrossRefPubMedPubMedCentral
19.
go back to reference Chong H, Gong Y, Pan X et al (2021) Peritumoral dilation radiomics of gadoxetate disodium-enhanced MRI excellently predicts early recurrence of hepatocellular carcinoma without macrovascular invasion after hepatectomy. J Hepatocell Carcinoma 8:545–563CrossRefPubMedPubMedCentral Chong H, Gong Y, Pan X et al (2021) Peritumoral dilation radiomics of gadoxetate disodium-enhanced MRI excellently predicts early recurrence of hepatocellular carcinoma without macrovascular invasion after hepatectomy. J Hepatocell Carcinoma 8:545–563CrossRefPubMedPubMedCentral
22.
go back to reference Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V (2018) Tree-based methods for characterising tumor density heterogeneity. Pac Symp Biocomput 23:216–227PubMedPubMedCentral Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V (2018) Tree-based methods for characterising tumor density heterogeneity. Pac Symp Biocomput 23:216–227PubMedPubMedCentral
23.
go back to reference Elmohr MM, Fuentes D, Habra MA et al (2019) Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT. Clin Radiol 74:818 e811–818 e817CrossRef Elmohr MM, Fuentes D, Habra MA et al (2019) Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT. Clin Radiol 74:818 e811–818 e817CrossRef
24.
go back to reference Shi B, Zhang GM, Xu M, Jin ZY, Sun H (2019) Distinguishing metastases from benign adrenal masses: what can CT texture analysis do? Acta Radiol 60:1553–1561CrossRefPubMed Shi B, Zhang GM, Xu M, Jin ZY, Sun H (2019) Distinguishing metastases from benign adrenal masses: what can CT texture analysis do? Acta Radiol 60:1553–1561CrossRefPubMed
25.
go back to reference Lee HY, Oh YL, Park SY (2021) Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions. Eur Radiol 31:5948–5958CrossRefPubMed Lee HY, Oh YL, Park SY (2021) Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions. Eur Radiol 31:5948–5958CrossRefPubMed
26.
27.
go back to reference Mazzella A, Loi M, Mansuet-Lupo A et al (2019) Clinical characteristics, molecular phenotyping, and management of isolated adrenal metastases from lung cancer. Clin Lung Cancer 20:405–411CrossRefPubMed Mazzella A, Loi M, Mansuet-Lupo A et al (2019) Clinical characteristics, molecular phenotyping, and management of isolated adrenal metastases from lung cancer. Clin Lung Cancer 20:405–411CrossRefPubMed
28.
go back to reference Moreno P, de la Quintana BA, Musholt TJ et al (2013) Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery 154:1215–1222 discussion 1222-1213CrossRefPubMed Moreno P, de la Quintana BA, Musholt TJ et al (2013) Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery 154:1215–1222 discussion 1222-1213CrossRefPubMed
29.
go back to reference Andersen MB, Bodtger U, Andersen IR, Thorup KS, Ganeshan B, Rasmussen F (2021) Metastases or benign adrenal lesions in patients with histopathological verification of lung cancer: Can CT texture analysis distinguish? Eur J Radiol 138:109664CrossRefPubMed Andersen MB, Bodtger U, Andersen IR, Thorup KS, Ganeshan B, Rasmussen F (2021) Metastases or benign adrenal lesions in patients with histopathological verification of lung cancer: Can CT texture analysis distinguish? Eur J Radiol 138:109664CrossRefPubMed
30.
go back to reference Moawad AW, Ahmed A, Fuentes DT, Hazle JD, Habra MA, Elsayes KM (2021) Machine learning-based texture analysis for differentiation of radiologically indeterminate small adrenal tumors on adrenal protocol CT scans. Abdom Radiol (NY) 46:4853–4863CrossRefPubMed Moawad AW, Ahmed A, Fuentes DT, Hazle JD, Habra MA, Elsayes KM (2021) Machine learning-based texture analysis for differentiation of radiologically indeterminate small adrenal tumors on adrenal protocol CT scans. Abdom Radiol (NY) 46:4853–4863CrossRefPubMed
31.
go back to reference Ho LM, Samei E, Mazurowski MA et al (2019) Can texture analysis be used to distinguish benign from malignant adrenal nodules on unenhanced CT, contrast-enhanced CT, or In-phase and opposed-phase MRI? AJR Am J Roentgenol 212:554–561CrossRefPubMed Ho LM, Samei E, Mazurowski MA et al (2019) Can texture analysis be used to distinguish benign from malignant adrenal nodules on unenhanced CT, contrast-enhanced CT, or In-phase and opposed-phase MRI? AJR Am J Roentgenol 212:554–561CrossRefPubMed
32.
go back to reference Nagayama Y, Inoue T, Oda S et al (2020) Adrenal adenomas versus metastases: diagnostic performance of dual-energy spectral CT virtual noncontrast imaging and iodine maps. Radiology 296:324–332CrossRefPubMed Nagayama Y, Inoue T, Oda S et al (2020) Adrenal adenomas versus metastases: diagnostic performance of dual-energy spectral CT virtual noncontrast imaging and iodine maps. Radiology 296:324–332CrossRefPubMed
33.
go back to reference Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 202:1043–1050CrossRefPubMed Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 202:1043–1050CrossRefPubMed
34.
go back to reference Marty M, Gaye D, Perez P et al (2018) Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population. Eur J Endocrinol 178:439–446CrossRefPubMed Marty M, Gaye D, Perez P et al (2018) Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population. Eur J Endocrinol 178:439–446CrossRefPubMed
35.
go back to reference Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A (2016) Differentiation of benign from metastatic adrenal masses in patients with renal cell carcinoma on contrast-enhanced CT. AJR Am J Roentgenol 207:1031–1038CrossRefPubMed Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A (2016) Differentiation of benign from metastatic adrenal masses in patients with renal cell carcinoma on contrast-enhanced CT. AJR Am J Roentgenol 207:1031–1038CrossRefPubMed
Metadata
Title
Two nomograms based on radiomics models using triphasic CT for differentiation of adrenal lipid-poor benign lesions and metastases in a cancer population: an exploratory study
Authors
Gongzheng Wang
Bing Kang
Jingjing Cui
Yan Deng
Yun Zhao
Congshan Ji
Ximing Wang
Publication date
20-10-2022
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2023
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-09182-8

Other articles of this Issue 3/2023

European Radiology 3/2023 Go to the issue